Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy

Circ Cardiovasc Imaging. 2019 Jun;12(6):e009104. doi: 10.1161/CIRCIMAGING.119.009104. Epub 2019 Jun 10.

Francesca Graziani¹, Rosa Lillo^{1

2}, Elena Panaioli^{1

2}, Gionata Spagnoletti³, Isabella Bruno⁴, Lucia Leccisotti⁵, Riccardo Marano^{6

2}, Raffaele Manna², Filippo Crea^{1

2}

¹ Department of Cardiovascular and Thoracic Sciences (F.G., R.L., E.P., F.C.), Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.
² Università Cattolica del Sacro Cuore, Rome, Italy (R.L., E.P., R. Marano, R. Manna, F.C.).
³ Renal Transplant Unit (G.S.), Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.
⁴ Nuclear Medicine Unit (I.B., L.L.), Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.
⁵ Diagnostic Imaging Area (R. Marano), Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.
⁶ Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Rare diseases and Periodic Fever Research Centre, Department of Internal Medicine (R. Manna), Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.

No abstract available

Keywords: Fabry disease; galactosidases; hypertrophy; morbidity; mortality.

Publication types